Analysts’ Viewpoint
Advancements in nanotechnology and materials science, and marked improvement in manufacturing methods for creating innovative nanoparticles are the key factors expected to drive the nanoparticle contract manufacturing market growth during the forecast period. Escalating demand for advanced drug delivery systems, diagnostics, and therapeutic solutions in healthcare, and usage in electronics, and energy sectors is also fueling market progress.
Furthermore, surge in research investments, supported by government initiatives and collaborations between academic institutions and industries, have hastened nanoparticle technology innovations. The expanding utilization of nanoparticles in pharmaceuticals, electronics, and environmental engineering is likely to offer lucrative opportunities for nanoparticle contract manufacturing market expansion.
A heightened focus on green manufacturing and sustainability is encouraging the development of eco-friendly nanoparticle production methods, contributing significantly to overall market development.
The nanoparticle contract manufacturing sector outsources nanoparticle production to specialized manufacturers. These manufacturers operate at a large scale, benefiting from economies of scale, which attracts businesses seeking to cut production expenses. Companies often choose contract manufacturing to reduce costs. Thus, cost-effectiveness is a major incentive for companies aiming to streamline their budgets.
Advancements in this sector have led to various nanoparticle types such as gold and silver metal nanoparticles, liposomes, and dendrimers. These nanoparticles possess unique features such as high surface area-to-volume ratios, customizable surface chemistry, and specific sizes. They find applications across diverse industries, especially in healthcare for drug delivery, diagnostics, and therapeutics.
Nanomedicine is an innovative healthcare approach utilizing nanotechnology to advance drug delivery, efficacy, and reduce side effects, transforming the pharmaceutical industry. Nanoparticle contract manufacturing has become essential to meet its intricate demands. Outsourcing to specialized manufacturers helps handle nanomedicine's complex formulations and precise control requirements.
Adaptability of nanocarriers encapsulates various therapeutic compounds, broadening nanomedicine's applications in oncology, neurology, and other fields. Surge in chronic diseases and aging populations escalate nanomedicine demand due to unique features of nanoparticles, such as extended circulation and enhanced permeability, suitable for complex chronic conditions.
Thus, outsourcing of nanomedicine production to specialized contract manufacturers is poised to play a key role in meeting the burgeoning demand for these advanced therapeutic formulations and is an important market catalyst.
Outsourcing the production of nanomedicine to contract manufacturers significantly diminishes costs, sparing product manufacturers from expending vital in-house resources on manufacturing. Collaboration with contract manufacturers (CMs) removes the complexities associated with handling multiple vendors, averting unforeseen expenses, and curbing overall labor costs.
Additionally, CMs offer exclusive technical insights that are otherwise inaccessible. Given their diverse clientele, CMs possess invaluable expertise in product development across various specialized fields, providing businesses with a wealth of knowledge.
Entrusting the entire manufacturing process to a contract manufacturer creates ample internal opportunities for companies. This approach enables a shift in focus, allowing employees to concentrate on innovation, devising inventive prototypes, and conceptualizing pioneering products. This newfound flexibility empowers employees to direct their attention toward crucial aspects of product development, fostering innovation and bolstering competitive advantage.
Its pivotal role in enhancing innovation and operational efficiency across diverse businesses is bolstering the nanomedicine contract manufacturing market value.
The nanoparticle contract manufacturing market segmentation based on type of nanoparticles is divided into metal nanoparticles, lipid nanoparticles, and others.
Metal nanoparticles dominate the nanoparticle contract manufacturing sector owing to their varied applications and distinctive traits. Their adaptability enables usage across various industries especially healthcare. Gold, silver, and iron oxide nanoparticles possess remarkable characteristics, including high surface area-to-volume ratio, customizable surface chemistry, and exceptional catalytic abilities, making them highly sought-after for drug delivery, diagnostics, therapeutics, and sensor innovation.
In the medical field, a surge in demand is seen for metal nanoparticles, especially in cancer therapy and diagnostics, due to their precision in targeting specific cells or tissues for therapeutic delivery. Extensive research and development endeavors aimed at harnessing metal nanoparticles for pioneering technologies has solidified their prominence in the nanoparticle contract manufacturing domain.
Based on manufacturing scale, the market is classified into commercial, clinical, and pre-clinical. As per the nanoparticle contract manufacturing market analysis, commercial-scale production commands a substantial share owing to its widespread application across diverse industries, catering to extensive demand in the healthcare, electronics, and energy sectors.
The recent upsurge in nanotechnology has fueled rapid expansion of commercial-scale nanoparticle manufacturing, driven by increase in need for nanomaterials across various applications. Pharmaceutical manufacturers, for instance, increasingly rely on this scale to produce nanoparticles vital for enhancing drug delivery systems for improved therapeutic efficacy and targeted cell treatments.
Industries such as electronics and energy utilize nanoparticles to enhance battery technologies and streamline electronic devices. This heightened demand has prompted collaborations and strategic partnerships among industry leaders, aiming to augment production capacities and address the growing nanoparticle requirements across multifaceted sectors.
In terms of application, the nanoparticle contract manufacturing market includes therapeutics, diagnostics, and vaccines. The increase in need for innovative drug delivery methods, along with ongoing advancements in nanoparticle technology, has significantly elevated the importance of therapeutic applications in the nanoparticle contract manufacturing sector.
Nanoparticles function as effective vehicles for medications, delivering them precisely to particular cells or body tissues, thus improving treatment efficiency and reducing potential adverse effects. Their adaptability enables the encapsulation of various therapeutic substances such as medicines, proteins, and genetic materials, expanding their potential across oncology, infectious diseases, and chronic illnesses and offering lucrative nanoparticle contract manufacturing market opportunities.
According to the latest nanoparticle contract manufacturing market forecast, North America's dominance in the landscape stems from its advanced healthcare infrastructure, prominent pharmaceutical and biotechnology firms, and substantial investments in research and development. The United States, especially, leads in nanotechnology innovation and implementation across various sectors. Technological strides, supported by government initiatives and substantial funding for nanotechnology research plays a key role in North America's leadership in the global market.
The Nanoparticle Contract Manufacturing market in Europe demonstrates noteworthy growth, attributed to a substantial CAGR, emphasizing eco-friendly methods in nanoparticle manufacturing and their incorporation across diverse sectors. These include drug delivery systems, electronics, and renewable energy solutions. Collaborative efforts between academic institutions and industries are driving pioneering advancements in nanoparticle research.
Rapid growth of the APAC market, marked by the highest CAGR, is attributed to notable advancements in nanotechnology and materials science. These advancements have driven innovation in nanoparticle manufacturing techniques. Additionally, increase in demand for cutting-edge drug delivery systems, electronics, and energy solutions have led to widespread adoption of nanoparticles across multiple industries in the region.
The global nanoparticle contract manufacturing market share is fragmented with the presence of a number of players. Key players in the market are AstraZeneca, Inc., Evonik Industries AG, Ascendia Pharmaceuticals, Axolabs (LGC Limited), AVANSA Technology & Services, Ardena Holding NV, Cytodiagnostics, Inc., American Elements, Encapsula NanoSciences LLC, Fortis Life Sciences, Hongwu International Group Ltd., MyBiotech, and Nanochemazone.
Each of these players have been profiled in the nanoparticle contract manufacturing market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 2.2 Bn |
| Market Forecast Value in 2031 | More than US$ 4.3 Bn |
| CAGR - 2023–2031 | 7.7% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
It was valued at US$ 2.2 Bn in 2022
It is projected to reach more than US$ 4.3 Bn by the end of 2031
The CAGR is anticipated to be 7.7% from 2023 to 2031
North America is expected to account for largest share from 2023 to 2031
AstraZeneca, Inc., Evonik Industries AG, Ascendia Pharmaceuticals, Axolabs (LGC Limited), AVANSA Technology & Services, Ardena Holding NV, Cytodiagnostics, Inc., American Elements, Encapsula NanoSciences LLC, Fortis Life Sciences, Hongwu International Group Ltd., MyBiotech, and Nanochemazone
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nanoparticle Contract Manufacturing Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Nanoparticle Contract Manufacturing Market Value Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Key Industry Events
5.2. Technological Advancements
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)
6. Global Nanoparticle Contract Manufacturing Market Analysis, by Type of Nanoparticles
6.1. Introduction
6.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by Type of Nanoparticles
6.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles
6.4. Global Nanoparticle Contract Manufacturing Market Analysis, by Type of Nanoparticles
6.5. Global Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
6.5.1. Metal Nanoparticles
6.5.2. Lipid Nanoparticles
6.5.3. Others
7. Global Nanoparticle Contract Manufacturing Market Analysis, by Manufacturing Scale
7.1. Introduction
7.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by Manufacturing Scale
7.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale
7.4. Global Nanoparticle Contract Manufacturing Market Analysis, by Manufacturing Scale
7.5. Global Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
7.5.1. Commercial
7.5.2. Clinical
7.5.3. Pre-clinical
8. Global Nanoparticle Contract Manufacturing Market Analysis, by Application
8.1. Introduction
8.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by Application
8.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application
8.4. Global Nanoparticle Contract Manufacturing Market Analysis, by Application
8.5. Global Nanoparticle Contract Manufacturing Market Forecast, by Application
8.5.1. Therapeutics
8.5.2. Diagnostics
8.5.3. Vaccines
9. Global Nanoparticle Contract Manufacturing Market Analysis, by End-user
9.1. Introduction
9.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by End-user
9.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user
9.4. Global Nanoparticle Contract Manufacturing Market Analysis, by End-user
9.5. Global Nanoparticle Contract Manufacturing Market Forecast, by End-user
9.5.1. Pharmaceutical Companies
9.5.2. Biotechnology Companies
10. Global Nanoparticle Contract Manufacturing Market Analysis, by Region
10.1. Introduction
10.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by Region
10.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Region
10.4. Global Nanoparticle Contract Manufacturing Market Forecast, by Region
10.4.1. North America
10.4.2. Europe
10.4.3. Asia Pacific
10.4.4. Latin America
10.4.5. Middle East & Africa
11. North America Nanoparticle Contract Manufacturing Market Analysis
11.1. Key Insights: North America Nanoparticle Contract Manufacturing Market
11.2. North America Nanoparticle Contract Manufacturing Market Overview
11.3. North America Nanoparticle Contract Manufacturing Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Type of Nanoparticles
11.5. North America Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
11.5.1. Metal Nanoparticles
11.5.2. Lipid Nanoparticles
11.5.3. Others
11.6. North America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
11.7. North America Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
11.7.1. Commercial
11.7.2. Clinical
11.7.3. Pre-clinical
11.8. North America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Application
11.9. North America Nanoparticle Contract Manufacturing Market Forecast, by Application
11.9.1. Therapeutics
11.9.2. Diagnostics
11.9.3. Vaccines
11.10. North America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
11.11. North America Nanoparticle Contract Manufacturing Market Forecast, by End-user
11.11.1. Pharmaceutical Companies
11.11.2. Biotechnology Companies
12. Europe Nanoparticle Contract Manufacturing Market Analysis
12.1. Key Insights: Europe Nanoparticle Contract Manufacturing Market
12.2. Europe Nanoparticle Contract Manufacturing Market Overview
12.3. Europe Nanoparticle Contract Manufacturing Market Forecast, by Country
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Type of Nanoparticles
12.5. Europe Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
12.5.1. Metal Nanoparticles
12.5.2. Lipid Nanoparticles
12.5.3. Others
12.6. Europe Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
12.7. Europe Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
12.7.1. Commercial
12.7.2. Clinical
12.7.3. Pre-clinical
12.8. Europe Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Application
12.9. Europe Nanoparticle Contract Manufacturing Market Forecast, by Application
12.9.1. Therapeutics
12.9.2. Diagnostics
12.9.3. Vaccines
12.10. Europe Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
12.11. Europe Nanoparticle Contract Manufacturing Market Forecast, by End-user
12.11.1. Pharmaceutical Companies
12.11.2. Biotechnology Companies
13. Asia Pacific Nanoparticle Contract Manufacturing Market Analysis
13.1. Key Insights: Asia Pacific Nanoparticle Contract Manufacturing Market
13.2. Asia Pacific Nanoparticle Contract Manufacturing Market Overview
13.3. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Country
13.3.1. China
13.3.2. Japan
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis,
13.4.1. by Type of Nanoparticles
13.5. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
13.5.1. Metal Nanoparticles
13.5.2. Lipid Nanoparticles
13.5.3. Others
13.6. Asia Pacific Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
13.7. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
13.7.1. Commercial
13.7.2. Clinical
13.7.3. Pre-clinical
13.8. Asia Pacific Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Application
13.9. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Application
13.9.1. Therapeutics
13.9.2. Diagnostics
13.9.3. Vaccines
13.10. Asia Pacific Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
13.11. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by End-user
13.11.1. Pharmaceutical Companies
13.11.2. Biotechnology Companies
14. Latin America Nanoparticle Contract Manufacturing Market Analysis
14.1. Key Insights: Latin America Nanoparticle Contract Manufacturing Market
14.2. Latin America Nanoparticle Contract Manufacturing Market Overview
14.3. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Country
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Type of Nanoparticles
14.5. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
14.5.1. Metal Nanoparticles
14.5.2. Lipid Nanoparticles
14.5.3. Others
14.6. Latin America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
14.7. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
14.7.1. Commercial
14.7.2. Clinical
14.7.3. Pre-clinical
14.8. Latin America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis,by Application
14.9. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Application
14.9.1. Therapeutics
14.9.2. Diagnostics
14.9.3. Vaccines
14.10. Latin America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
14.11. Latin America Nanoparticle Contract Manufacturing Market Forecast, by End-user
14.11.1. Pharmaceutical Companies
14.11.2. Biotechnology Companies
15. Middle East & Africa Nanoparticle Contract Manufacturing Market Analysis
15.1. Key Insights: Middle East & Africa Nanoparticle Contract Manufacturing Market
15.2. Middle East & Africa Nanoparticle Contract Manufacturing Market Overview
15.3. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Country
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Type of Nanoparticles
15.5. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
15.5.1. Metal Nanoparticles
15.5.2. Lipid Nanoparticles
15.5.3. Others
15.6. Middle East & Africa Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
15.7. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
15.7.1. Commercial
15.7.2. Clinical
15.7.3. Pre-clinical
15.8. Middle East & Africa Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Application
15.9. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Application
15.9.1. Therapeutics
15.9.2. Diagnostics
15.9.3. Vaccines
15.10. Middle East & Africa Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
15.11. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by End-user
15.11.1. Pharmaceutical Companies
15.11.2. Biotechnology Companies
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. AstraZeneca
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategies
16.3.1.5. Recent Developments
16.3.2. Evonik Industries AG
16.3.2.1. Company Overview
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Business Strategies
16.3.2.5. Recent Developments
16.3.3. Ascendia Pharmaceuticals
16.3.3.1. Company Overview
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Business Strategies
16.3.3.5. Recent Developments
16.3.4. Axolabs (LGC Limited)
16.3.4.1. Company Overview
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Business Strategies
16.3.4.5. Recent Developments
16.3.5. AVANSA Technology & Services
16.3.5.1. Company Overview
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Business Strategies
16.3.5.5. Recent Developments
16.3.6. Ardena Holding NV.
16.3.6.1. Company Overview
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Business Strategies
16.3.6.5. Recent Developments
16.3.7. Cytodiagnostics, Inc.
16.3.7.1. Company Overview
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Business Strategies
16.3.7.5. Recent Developments
16.3.8. American Elements
16.3.8.1. Company Overview
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. Business Strategies
16.3.8.5. Recent Developments
16.3.9. Encapsula NanoSciences LLC
16.3.9.1. Company Overview
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. Business Strategies
16.3.9.5. Recent Developments
16.3.10. Fortis Life Sciences
16.3.10.1. Company Overview
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. Business Strategies
16.3.10.5. Recent Developments
16.3.11. Hongwu International Group Ltd.
16.3.11.1. Company Overview
16.3.11.2. Financial Overview
16.3.11.3. Product Portfolio
16.3.11.4. Business Strategies
16.3.11.5. Recent Developments
16.3.12. MyBiotech
16.3.12.1. Company Overview
16.3.12.2. Financial Overview
16.3.12.3. Product Portfolio
16.3.12.4. Business Strategies
16.3.12.5. Recent Developments
16.3.13. Nanochemazone
16.3.13.1. Company Overview
16.3.13.2. Financial Overview
16.3.13.3. Product Portfolio
16.3.13.4. Business Strategies
16.3.13.5. Recent Developments
List of Tables
Table 01: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticles, 2017-2031
Table 02: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
Table 03: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
Table 08: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
Table 09: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 10: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 12: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
Table 13: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
Table 14: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 15: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 17: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
Table 18: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
Table 19: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 22: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
Table 23: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
Table 24: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 25: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 27: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
Table 28: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
Table 29: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 30: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Nanoparticle Contract Manufacturing Market Size, by Type of Nanoparticles, 2022
Figure 02: Nanoparticle Contract Manufacturing Market share (%), by Type of Nanoparticles, 2022
Figure 03: Global Nanoparticle Contract Manufacturing Market Size, by Manufacturing Scale, 2022
Figure 04: Nanoparticle Contract Manufacturing Market share (%), by Manufacturing Scale, 2022
Figure 05: Global Nanoparticle Contract Manufacturing Market Size, by Application, 2022
Figure 06: Nanoparticle Contract Manufacturing Market share (%), by Application, 2022
Figure 07: Global Nanoparticle Contract Manufacturing Market Size, by End-user, 2022
Figure 08: Nanoparticle Contract Manufacturing Market share (%), by End-user, 2022
Figure 09: Global Nanoparticle Contract Manufacturing Market, By Region (2022 and 2031)
Figure 10: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, 2023–2031
Figure 11: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Share Analysis, by Type of Nanoparticle, 2022 and 2031
Figure 12: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Type of Nanoparticles, 2022
Figure 13: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Type of Nanoparticles, 2031
Figure 14: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023–2031
Figure 15: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Metal Nanoparticles, 2023‒2031
Figure 16: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Metal Nanoparticles, 2022 and 2031
Figure 17: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Lipid Nanoparticles, 2023‒2031
Figure 18: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Lipid Nanoparticles, 2022 and 2031
Figure 19: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Others, 2023‒2031
Figure 20: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Others, 2022 and 2031
Figure 21: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Share Analysis, by Manufacturing Scale, 2022 and 2031
Figure 22: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Manufacturing Scale, 2022
Figure 23: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Manufacturing Scale, 2031
Figure 24: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023–2031
Figure 25: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Commercial, 2023‒2031
Figure 26: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Commercial, 2022 and 2031
Figure 27: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Clinical, 2023‒2031
Figure 28: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Clinical, 2022 and 2031
Figure 29: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Pre-clinical, 2023‒2031
Figure 30: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Pre-clinical, 2022 and 2031
Figure 31: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 32: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Application, 2022
Figure 33: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Application, 2031
Figure 34: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Therapeutics, 2023‒2031
Figure 36: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Therapeutics, 2022 and 2031
Figure 37: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Diagnostics, 2023‒2031
Figure 38: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Diagnostics, 2022 and 2031
Figure 39: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Vaccines, 2023‒2031
Figure 40: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Vaccines, 2022 and 2031
Figure 41: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 42: Global Nanoparticle Contract Manufacturing Market Share Analysis, by End-user, 2022
Figure 43: Global Nanoparticle Contract Manufacturing Market Share Analysis, by End-user, 2031
Figure 44: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Pharmaceutical Companies, 2023‒2031
Figure 46: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Pharmaceutical Companies, 2022 and 2031
Figure 47: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Biotechnology Companies, 2023‒2031
Figure 48: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Biotechnology Companies, 2022 and 2031
Figure 49: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Region, 2022 and 2031
Figure 50: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Region, 2023–2031
Figure 51: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 52: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
Figure 53: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023–2031
Figure 54: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
Figure 55: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023–2031
Figure 56: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
Figure 57: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023–2031
Figure 58: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
Figure 59: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023–2031
Figure 60: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 61: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 62: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 63: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
Figure 64: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023–2031
Figure 65: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
Figure 66: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023–2031
Figure 67: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
Figure 68: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023–2031
Figure 69: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
Figure 70: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023–2031
Figure 71: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 72: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 73: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 74: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
Figure 75: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023–2031
Figure 76: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
Figure 77: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023–2031
Figure 78: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
Figure 79: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023–2031
Figure 80: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
Figure 81: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023–2031
Figure 82: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 83: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 84: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 85: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
Figure 86: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023–2031
Figure 87: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
Figure 88: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023–2031
Figure 89: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
Figure 90: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023–2031
Figure 91: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
Figure 92: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023–2031
Figure 93: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 94: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 95: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 96: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
Figure 97: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023–2031
Figure 98: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
Figure 99: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023–2031
Figure 100: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
Figure 101: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023–2031
Figure 102: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
Figure 103: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023–2031
Figure 104: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 105: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Nanoparticle Contract Manufacturing Market
*86 figures and 60 tables includes